The FDA revoked approval of the use of a popular breast cancer drug Avastin. It was found that Avastin exposed users to potentially harmful side effects such as severe high blood pressure and hemorrhaging. Even with this news Avastin will remain on the market where Doctors can still prescribe it to breast cancer patients but with the revoking of FDA approval it will likely cost breast cancer patients $88,000 a year which would be too costly for most.
Shocking news that scientists have caught up with the public they have found merit to medical marijuana. The Institute of Medicine has published a study stating that they found merit to cannabis. Just had to share please pass along. The study is from 1999 so it is curious why the government still claims no medicinal value to cannabis.
IOM finds scientific merit to medical marijuana. Institute of Medicine
More related articles for you to enjoy
- Integrative Medicine: Legalization and regulation of cannabis (cherrygurl28.com)
- Breast Cancer Advocates Decry FDA Vote to Remove Life-Saving Drug From Market (prnewswire.com)
- Medical Marijuana Crackdown Should Stop, House Reps Say (huffingtonpost.com)
- Colorado’s Marijuana ‘Green Rush’ (businessweek.com)
- Medicinal Use of Cannabis in the United States: Historical Perspectives, Current Trends, and Future Directions (cherrygurl28.com)
- CBS Poll: Yes to Medical Marijuana, But What We Have Now Isn’t So Medicinal (reason.com)
- DEA raids Ballard medical marijuana dispensary (myballard.com)